Trupanion, Inc. filings document the company’s pet medical insurance business, public-company governance, and capital structure. Form 8-K reports include quarterly and annual operating results, with disclosures on subscription revenue, enrolled pets, net acquisition cost, adjusted EBITDA, operating cash flow, and other measures used to describe the company’s insurance economics.
The filing record also covers material agreements, including credit facilities, secured borrowings, maturity terms, covenants, and limits on corporate actions. Proxy materials document director elections, board composition, executive compensation, equity awards, shareholder voting matters, and related governance disclosures.
TRUPANION, INC. (TRUP) reported that Chief Legal Officer Asher Bearman had multiple restricted stock unit (RSU) awards vest on August 22 and 25, 2026, converting an aggregate 2,610 RSUs into an equal number of shares of common stock.
In connection with these vestings, a total of 841 shares of common stock were withheld by the issuer to satisfy income tax withholding obligations at prices of about $31.76–$31.84 per share, which the company specifies do not represent market sales by the reporting person.
TRUPANION, INC. (TRUP) reported that executive officer Steve Weinrauch, EVP, North America & Vet Strategy, exercised previously granted restricted stock units (RSUs) into a total of 4,859 shares of common stock on August 22 and 25, 2026. The RSUs convert into common shares on a one-for-one basis. In connection with these vestings, a total of 1,181 common shares were delivered or withheld to satisfy income tax withholding and remittance obligations, which the company notes do not represent sales by the reporting person.
TRUPANION, INC. (TRUP) reported that Chief Administration Officer Brenna McGibney had restricted stock units vest on August 22 and 25, 2026, converting a total of 6,430 RSUs into common stock. To cover income tax withholding, the issuer withheld 3,438 common shares at prices of $31.76 and $31.84 per share, which the company states do not represent a sale by McGibney. All transactions were non‑open‑market RSU vesting, with no reported discretionary share sales.
TRUPANION, INC. (TRUP) reported that executive vice president Simon Wheeler had restricted stock units vest and convert into common stock on August 22 and 25, 2026. In total, 2,173 RSUs were exercised into an equal number of common shares, and 1,085 shares were withheld by the issuer to satisfy income tax withholding and remittance obligations. Footnotes state these withholdings do not represent sales by the reporting person.
TRUPANION, INC. (TRUP) Chief Financial Officer Fawwad Qureshi reported multiple equity transactions. On 2026-08-26, he sold 6,111 shares of common stock in open-market or private transactions at a weighted average price of $30.01 per share. Around 2026-08-22 and 2026-08-25, a total of 13,746 restricted stock units (RSUs) converted into an equal number of common shares, while 5,486 shares were withheld by the issuer at prices around $31.76–$31.84 per share solely to satisfy income tax withholding and remittance obligations, which the company states do not represent sales by Qureshi.
TRUPANION, INC. (TRUP) CEO and director Margaret Tooth reported multiple equity compensation transactions. On August 22 and 25, 2026 she exercised and vested 19,042 RSUs into the same number of common shares. Of these, 7,000 shares were withheld by the issuer to cover income tax obligations and 491 shares were sold in a market transaction at $31.84 per share. The remaining shares from these RSU conversions increased her directly held common stock, although post-transaction holdings are not stated here.
TRUPANION, INC. (TRUP) reported Form 4 activity by Chief Operating Officer John R. Gallagher. On August 22 and 25, 2026, Gallagher exercised restricted stock units (RSUs) into common stock and had a portion of the resulting shares withheld by the issuer to cover income tax obligations. Footnotes state these withheld shares represent tax withholding and remittance, not market sales by Gallagher, and overall activity reflects RSU vesting rather than open-market trading.
TRUPANION, INC. (TRUP) director Darryl Rawlings reported an automatic conversion of 313 Restricted Stock Units (RSUs) into 313 shares of common stock on 2026-08-22. Following the transactions, he holds 1,875 RSUs and 25,151 common shares directly. The RSUs were part of a 5,000-unit grant awarded on 2024-02-27 that vests as to one-quarter on 2025-02-22 and then one-sixteenth of the total grant quarterly, subject to continued service through each vesting date.
TRUPANION, INC. (TRUP) received a Rule 144 notice from officer Fawwad Qureshi covering a proposed sale of company common stock. The notice reports an intent to sell 6,111 shares of TRUP common stock, with an indicated aggregate market value of $183,372.78, through Morgan Stanley Smith Barney LLC on or after 08/26/2026.
The shares to be sold were acquired as restricted stock from the issuer, vesting during the period 08/22/2026 through 08/25/2026. The filing also notes that Qureshi sold 6,177 shares of TRUP common stock in the prior three months on 05/27/2026 for an aggregate sale price of $136,938.53.
TRUPANION, INC. CEO and director Margaret Tooth reported a sale of 978 shares of Common Stock on August 11, 2026 at $29.05 per share. After this transaction, she directly held 175,401 shares. The sale was effected under a Rule 10b5-1(c) trading plan adopted on May 11, 2026, under which she had no discretion over trade timing and which was described as part of a plan of financial diversification.